Hims says Novo lawsuit over Wegovy patent "is a blatant attack"
Source: SeekingAlpha
2026-02-09 09:22:02 ET
More on Hims & Hers Health, Novo Nordisk
- Hims & Hers: Decelerating Growth And Cowboy Management, Material Downside Risk
- Hims & Hers: GLP-1 Revenues Can't Be Relied On
- Novo Nordisk: There's Plenty Of Value In Avoiding This Stock
- Novo soars, Hims & Hers sinks, following compounded drug drama
- Biggest stock movers Monday: SOFI, HIMS, and more
Read the full article on Seeking Alpha
For further details see:
Hims says Novo lawsuit over Wegovy patent “is a blatant attack”
LifeMD Inc.
NASDAQ: LFMD
LFMD Trading
10.43% G/L:
$4.075 Last:
2,055,236 Volume:
$4.02 Open:
LFMD Latest News
LFMD Stock Data
$146,092,411
39,278,882
2.54%
33
N/A
Healthcare Providers & Services
Healthcare
US
New York
